BGMSBio Green Med Solution, Inc.
Industrials
Operating Income (Loss) revised up 5.2% for Q2 2025
This is the 9th largest revision in BGMS's history.
Operating Income (Loss)·Q2 2025
Notable restatement-$1.2M▲ 5.2%
was-$1.3M
Revised up in a S-4/A.
Verify against SEC filingsShow
As reported-$1.3M
Accepted 2025-08-140001641172-25-023648
Restated-$1.2M
Accepted 2026-09-110001493152-26-042382
OperatingIncome · reported 4 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time BGMS — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.